194 related articles for article (PubMed ID: 18045060)
1. SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.
Johnson FM; Gallick GE
Anticancer Agents Med Chem; 2007 Nov; 7(6):651-9. PubMed ID: 18045060
[TBL] [Abstract][Full Text] [Related]
2. SRC family kinases as potential therapeutic targets for malignancies and immunological disorders.
Benati D; Baldari CT
Curr Med Chem; 2008; 15(12):1154-65. PubMed ID: 18473810
[TBL] [Abstract][Full Text] [Related]
3. Synthetic SRC-kinase domain inhibitors and their structural requirements.
Schenone S; Manetti F; Botta M
Anticancer Agents Med Chem; 2007 Nov; 7(6):660-80. PubMed ID: 18045061
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
5. Src family kinases in tumor progression and metastasis.
Summy JM; Gallick GE
Cancer Metastasis Rev; 2003 Dec; 22(4):337-58. PubMed ID: 12884910
[TBL] [Abstract][Full Text] [Related]
6. Src kinase inhibitors: promising cancer therapeutics?
Creedon H; Brunton VG
Crit Rev Oncog; 2012; 17(2):145-59. PubMed ID: 22471705
[TBL] [Abstract][Full Text] [Related]
7. Src continues aging: current and future clinical directions.
Kopetz S; Shah AN; Gallick GE
Clin Cancer Res; 2007 Dec; 13(24):7232-6. PubMed ID: 18094400
[TBL] [Abstract][Full Text] [Related]
8. The role of Src in solid tumors.
Wheeler DL; Iida M; Dunn EF
Oncologist; 2009 Jul; 14(7):667-78. PubMed ID: 19581523
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
Montero JC; Seoane S; Ocaña A; Pandiella A
Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
[TBL] [Abstract][Full Text] [Related]
10. The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy.
Lieu C; Kopetz S
Clin Colorectal Cancer; 2010 Apr; 9(2):89-94. PubMed ID: 20378502
[TBL] [Abstract][Full Text] [Related]
11. Recent progress of SRC family kinase inhibitors as anticancer agents.
Cao X; You QD; Li ZY; Wang XJ; Lu XY; Liu XR; Xu D; Liu B
Mini Rev Med Chem; 2008 Sep; 8(10):1053-63. PubMed ID: 18782057
[TBL] [Abstract][Full Text] [Related]
12. Targeting Src family kinases in anti-cancer therapies: turning promise into triumph.
Zhang S; Yu D
Trends Pharmacol Sci; 2012 Mar; 33(3):122-8. PubMed ID: 22153719
[TBL] [Abstract][Full Text] [Related]
13. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
14. Nonreceptor tyrosine kinases in prostate cancer.
Chang YM; Kung HJ; Evans CP
Neoplasia; 2007 Feb; 9(2):90-100. PubMed ID: 17357254
[TBL] [Abstract][Full Text] [Related]
15. Src inhibitors in breast cancer therapy.
Hiscox S; Nicholson RI
Expert Opin Ther Targets; 2008 Jun; 12(6):757-67. PubMed ID: 18479222
[TBL] [Abstract][Full Text] [Related]
16. Src signaling in cancer invasion.
Guarino M
J Cell Physiol; 2010 Apr; 223(1):14-26. PubMed ID: 20049846
[TBL] [Abstract][Full Text] [Related]
17. Basis and importance of Src as a target in cancer.
Levin VA
Cancer Treat Res; 2004; 119():89-119. PubMed ID: 15164875
[No Abstract] [Full Text] [Related]
18. Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer.
Edwards J
Expert Opin Investig Drugs; 2010 May; 19(5):605-14. PubMed ID: 20367532
[TBL] [Abstract][Full Text] [Related]
19. SRC: a century of science brought to the clinic.
Aleshin A; Finn RS
Neoplasia; 2010 Aug; 12(8):599-607. PubMed ID: 20689754
[TBL] [Abstract][Full Text] [Related]
20. Src-family tyrosine kinases as therapeutic targets in advanced cancer.
Gelman IH
Front Biosci (Elite Ed); 2011 Jun; 3(3):801-7. PubMed ID: 21622091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]